Search Results - BC Cancer Agency Library

Refine by:

Format

Audience

Date

Location

Author

Subject

Language

5 records – page 1 of 1.

Prev Next

New horizons in the treatment of breast cancer : selected proceedings from the 28th annual San Antonio Breast Cancer Symposium, December 8-11, 2005

https://bccalibrary.andornot.com/en/permalink/catalog14811

[Toronto, ON]: Kaleidoscope Strategic , 2006.

Audience: Professional

Call Number: WP870 N532m 2006

Availability: 1 copy, 1 available

Clinical symposia report : a Canadian perspective : feature review "Targeting optimal adjuvant therapy for Her2-positive breast cancer" (by Deanna McLeod and Zoe Agnidis)

Editor: Mackey, John R; McLeod, Deanna; Agnidis, Zoe

Place of Publication: [Toronto, ON]

Publisher: Kaleidoscope Strategic

Publication Date: 2006

Subjects: Breast Neoplasms - drug therapy; Antineoplastic Agents; Antibodies, Monoclonal - therapeutic use

Abstract: Clinical symposia report : a Canadian perspective : feature review "Targeting optimal adjuvant therapy for Her2-positive breast cancer" (by Deanna McLeod and Zoe Agnidis)

Language: English

Material Type: Book

Audience: Professional

Location: Vancouver Library

Call Number: WP870 N532m 2006

Copies

c.1 BC Cancer Agency VAN Library

Available

Administering Rituxan (rituximab) : a practical guide

https://bccalibrary.andornot.com/en/permalink/catalog18131

Hewitt, Karen, Zanke, Brent, Berinstein, Neil. Mississauga, ON: Hoffmann-La Roche Limited , 2000.

Audience: Patient or Public

Call Number: QZ267 A238 2000

Availability: 1 copy, 1 available

Author: Hewitt, Karen; Zanke, Brent; Berinstein, Neil

Place of Publication: Mississauga, ON

Publisher: Hoffmann-La Roche Limited

Publication Date: 2000

Physical Description: colour ; 15 minutes

Subjects: Antibodies, Monoclonal - therapeutic use; Lymphoma, Non-Hodgkin - therapy; Antineoplastic Agents - administration & dosage

Language: English

Material Type: DVD; Video

Audience: Patient or Public

Location: Vancouver Library

Call Number: QZ267 A238 2000

Copies

c.1 BC Cancer Agency VAN Library

Available

RANK ligand : a key signal in cancer-induced bone disease and hormone ablative therapy-induced bone loss

https://bccalibrary.andornot.com/en/permalink/catalog19811

Amgen Inc. Thousand Oaks, Calif.: Amgen Inc. , 2009.

Audience: Professional

Call Number: WE258 R198 2009

Availability: 1 copy, 1 available

Introduction; RANK ligand in bone biology; Bone metastases; Multiple myeloma; Skeletal-related events (SREs); Hormone ablative therapy-induced bone loss

Author: Amgen Inc.

Place of Publication: Thousand Oaks, Calif.

Publisher: Amgen Inc.

Publication Date: 2009

Subjects: RANK Ligand - metabolism; Osteoblasts; Osteoclasts; Antibodies, Monoclonal - therapeutic use; Bone Neoplasms - secondary; Bone Resorption; Osteoporosis - therapy; Antineoplastic Agents, Hormonal - adverse effects

Abstract: Introduction; RANK ligand in bone biology; Bone metastases; Multiple myeloma; Skeletal-related events (SREs); Hormone ablative therapy-induced bone loss